StockData
Celularity Inc logo

Celularity Inc (CELU) stock

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30
$0.48−0.09 (-15.41%)

Close on Nov 18, 2026Market cap $15.68MP/E –Yield –

Celularity free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Celularity's free cash flow for the twelve months ending Dec 31, 2024 was -$6.56M. For fiscal 2024 it was -$6.56M. The highest annual figure on record is -$6.56M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$6.56M–
FY2023Dec 31, 2023-$39.73M–
FY2022Dec 31, 2022-$143.11M–
FY2021Dec 31, 2021-$116.30M–
FY2020Dec 31, 2020-$91.03M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$1.50M–
Q3 FY2024Sep 30, 2024-$144.00K–
Q2 FY2024Jun 30, 2024-$3.48M–
Q1 FY2024Mar 31, 2024-$4.44M–
Q4 FY2023Dec 31, 2023-$4.92M–
Q3 FY2023Sep 30, 2023-$8.55M–
Q2 FY2023Jun 30, 2023-$11.06M–
Q1 FY2023Mar 31, 2023-$15.20M–
Q4 FY2022Dec 31, 2022-$30.36M–
Q3 FY2022Sep 30, 2022-$39.28M–
Q2 FY2022Jun 30, 2022-$37.76M–
Q1 FY2022Mar 31, 2022-$35.71M–
Q4 FY2021Dec 31, 2021-$34.35M–
Q3 FY2021Sep 30, 2021-$35.88M–
Q2 FY2021Jun 30, 2021-$19.51M–
Q1 FY2021Mar 31, 2021-$26.56M–
Q4 FY2020Dec 31, 2020-$26.20M–

More Celularity figures

See a number that looks wrong?